-transparent.png){kind=logo}
Fifty obese patients were entered into a 12-week parallel group study of mazindol with diethylpropion in a general practice group. Both drugs produced weight loss, but patients on mazindol lost 19.9 lbs in 12 weeks, while those on diethylpropion lost 11.6 lbs, a statistically significant difference (p less than 0.01). At each visit during the trial, patients had lost more weight with mazindol, but this was only significant statistically in the period 8-12 weeks (p less than 0.01). Patients developed tolerance to the effect of diethylpropion in the last period (8-12 weeks) but this was not evident in those patients taking mazindol. The number of side-effects was less in the mazindol group and mainly of an adrenergic, peripheral type, while those in the diethylpropion group are mainly of the central stimulant type.
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
October 1976,
Die Medizinische Welt,
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
January 1977,
Archiv fur Kriminologie,
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
April 1982,
Pediatria polska,
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
June 1976,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
June 1977,
La Clinica terapeutica,
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
May 1963,
The Journal of the College of General Practitioners,
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
January 1981,
Przeglad lekarski,
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
January 1975,
Current medical research and opinion,
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
March 2017,
Revista da Associacao Medica Brasileira (1992),
J E Murphy, and
J F Donald, and
A L Molla, and
D Crowder
February 1975,
Current therapeutic research, clinical and experimental,
